P699: MAGROLIMAB ALTERS THE TUMOR MICROENVIRONMENT TO IMPROVE BONE MARROW FUNCTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)

• Lisa Johnson,
• Yajia Zhang,
• Linda Su-Feher,
• Yeonju Lee,
• David A. Sallman,
• Adam S. Asch,
• Monzr M. Al Malki,
• Hyunjae Ryan Kim

Affiliations

Lisa Johnson

1 Gilead Sciences, Inc., Foster City, United States

Yajia Zhang

1 Gilead Sciences, Inc., Foster City, United States

Linda Su-Feher

1 Gilead Sciences, Inc., Foster City, United States

Yeonju Lee

1 Gilead Sciences, Inc., Foster City, United States

David A. Sallman

2 Moffitt Cancer Center, Tampa, United States

Adam S. Asch

3 University of Oklahoma, Oklahoma City, United States

Monzr M. Al Malki

4 City of Hope National Medical Center, Duarte, United States

Hyunjae Ryan Kim

1 Gilead Sciences, Inc., Foster City, United States